Your browser doesn't support javascript.
loading
Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
Clayton, Anita H; Lasser, Robert; Nandy, Indrani; Sankoh, Abdul J; Jonas, Jeffrey; Kanes, Stephen J.
Affiliation
  • Clayton AH; University of Virginia School of Medicine, Charlottesville, Virginia.
  • Lasser R; Corresponding author: Anita H. Clayton, MD, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, PO Box 800623, Charlottesville, VA 22908-0623 (ahc8v@hscmail.mcc.virginia.edu).
  • Nandy I; Sage Therapeutics, Inc, Cambridge, Massachusetts.
  • Sankoh AJ; Sage Therapeutics, Inc, Cambridge, Massachusetts.
  • Jonas J; Sage Therapeutics, Inc, Cambridge, Massachusetts.
  • Kanes SJ; Sage Therapeutics, Inc, Cambridge, Massachusetts.
J Clin Psychiatry ; 84(2)2023 02 20.
Article in En | MEDLINE | ID: mdl-36811520
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: J Clin Psychiatry Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: J Clin Psychiatry Year: 2023 Type: Article